Our goal is to undertake research that delivers innovations in prostate cancer diagnostics and management with the aim of improving patient outcomes in real time. To achieve these innovative improvements, we undertake a broad spectrum of work ranging from basic science to translational and clinical. We leverage the superb multidisciplinary skill set we have in Cambridge through our Translational Prostate Cancer Group and the wider Cambridge Cancer Centre Urological Malignancy Programme.
Our primary interest is to deliver improvements to all parts of the cancer pathway while ensuring that these changes are affordable and reduces the morbidity to patients from treatment. A key component to achieving our aims is to address the critical questions of how to detect lethal cancers. Equally critical is avoiding the problem of over-treatment, which is prevalent in current prostate cancer care. Importantly, we not only undertake research, we implement it within the context of day-to-day clinical care for patients. We apply our innovative research directly from bench to beside and back again in a cost effective and patient-centred way.